S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications. In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.
Metrics to compare | S2ME | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipS2MEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | 27.8x | −0.5x | |
PEG Ratio | −0.07 | 0.70 | 0.00 | |
Price/Book | 0.6x | 2.7x | 2.6x | |
Price / LTM Sales | 0.7x | 5.6x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 46.2% | |
Fair Value Upside | Unlock | 9.0% | 6.6% | Unlock |